Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Research is still evolving to identify all the ways semaglutide can affect your overall health. Even so, it probably makes ...

You might think that an intense burst of exercise would only make you more ravenous and reaching for piles of hot buttered ...

When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...

Ozempic. Wegovy and other GLP-1 medications have been hailed as groundbreaking treatments for individuals struggling with ...

Bev tipped the scales at 20st 7lbs and was left struggling to simply walk around her house - and even put socks on - due to ...